Organon Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Organon Co
OGN Stock  USD 15.62  0.31  2.02%   
Organon financial statements provide useful quarterly and yearly information to potential Organon Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Organon financial statements helps investors assess Organon's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Organon's valuation are summarized below:
Gross Profit
3.7 B
Profit Margin
0.1349
Market Capitalization
3.9 B
Enterprise Value Revenue
1.8982
Revenue
6.4 B
We have found one hundred twenty available trending fundamental ratios for Organon, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to check out Organon's recent fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 18th of March 2025, Enterprise Value is likely to drop to about 8.7 B

Organon Total Revenue

6.13 Billion

Check Organon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Organon's main balance sheet or income statement drivers, such as Interest Expense of 546 M, Selling General Administrative of 1.3 B or Total Revenue of 6.1 B, as well as many indicators such as Price To Sales Ratio of 1.01, Dividend Yield of 0.0434 or PTB Ratio of 8.53. Organon financial statements analysis is a perfect complement when working with Organon Valuation or Volatility modules.
  
Check out the analysis of Organon Correlation against competitors.

Organon Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets12.3 B13.1 B10.9 B
Slightly volatile
Short and Long Term Debt Total5.6 B8.9 B2.6 B
Slightly volatile
Other Current Liabilities1.4 B1.4 B791.4 M
Slightly volatile
Total Current Liabilities2.3 B2.7 B1.8 B
Slightly volatile
Other Liabilities239.4 M252 M1.8 B
Slightly volatile
Accounts Payable909.4 M1.2 B563 M
Slightly volatile
Cash608.8 M675 M402.2 M
Slightly volatile
Other Assets435.7 M485.1 M618.4 M
Slightly volatile
Cash And Short Term Investments608.8 M675 M402.2 M
Slightly volatile
Net Receivables1.6 B1.4 B1.5 B
Slightly volatile
Good Will5.1 B4.7 B4.6 B
Slightly volatile
Common Stock Shares Outstanding280.3 M259.2 M255.6 M
Slightly volatile
Liabilities And Stockholders Equity12.3 B13.1 B10.9 B
Slightly volatile
Inventory1.2 B1.3 B1 B
Slightly volatile
Other Current Assets768.5 M994 M903.8 M
Very volatile
Total Liabilities10.6 B12.6 B7 B
Slightly volatile
Total Current Assets4.3 B4.3 B3.9 B
Slightly volatile
Cash And Equivalents444 M811.9 M370.7 M
Slightly volatile
Intangible Assets806.3 M1.4 B777.1 M
Very volatile
Common Stock2.6 M2.7 M4.6 B
Slightly volatile
Property Plant Equipment1 B1.4 B850.2 M
Slightly volatile
Property Plant And Equipment Net1.1 B1.2 B826.7 M
Slightly volatile
Non Current Assets Total8 B8.8 B7 B
Slightly volatile
Non Currrent Assets Other1.1 B1.5 B845.9 M
Slightly volatile
Non Current Liabilities Total9.2 B9.9 B4.9 B
Slightly volatile
Property Plant And Equipment Gross1.8 B2.2 B1.1 B
Slightly volatile
Short and Long Term Debt19 M20 M109 M
Pretty Stable
Non Current Liabilities Other1.9 B977 M2.1 B
Very volatile
Net Working Capital1.4 B1.6 B2.2 B
Slightly volatile
Common Stock Total Equity2.4 M2.7 M2.9 M
Slightly volatile
Deferred Long Term Liabilities3.2 M3.6 M3.9 M
Slightly volatile

Organon Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense546 M520 M156.1 M
Slightly volatile
Selling General Administrative1.3 B1.8 B1.9 B
Slightly volatile
Total Revenue6.1 B6.4 B8.8 B
Slightly volatile
Gross Profit3.6 B3.7 B5.1 B
Slightly volatile
Operating Income1.8 B1.5 B2.6 B
Slightly volatile
EBIT1.8 B1.3 B2.7 B
Slightly volatile
Cost Of Revenue2.5 B2.7 B3.7 B
Slightly volatile
Income Before Tax766.6 M807 M2.4 B
Slightly volatile
Net Income Applicable To Common Shares1.5 B825.3 M1.7 B
Slightly volatile
Net Income1.3 B864 M1.7 B
Slightly volatile
Depreciation And Amortization350.6 M277 M1.1 B
Slightly volatile
Other Operating Expenses4 B4.9 B6 B
Slightly volatile
Net Income From Continuing Ops1.3 B864 M1.9 B
Slightly volatile
Research Development440 M469 M385 M
Slightly volatile
EBITDA2.1 B1.6 B3.5 B
Slightly volatile
Total Operating Expenses2.3 B2.2 B2.3 B
Slightly volatile
Reconciled Depreciation353.8 M277 M1.1 B
Slightly volatile
Selling And Marketing Expenses185.6 M188.1 M243.2 M
Slightly volatile
Non Recurring2.4 M2.7 M2.9 M
Slightly volatile

Organon Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation73.3 M105 M62.4 M
Slightly volatile
Free Cash Flow1.5 B764 M2.5 B
Slightly volatile
Begin Period Cash Flow599 M693 M666.7 M
Slightly volatile
Depreciation125.4 M132 M1.2 B
Slightly volatile
Capital Expenditures262.4 M175 M173.3 M
Slightly volatile
Total Cash From Operating Activities1.7 B939 M2.7 B
Slightly volatile
Net Income1.4 B864 M1.7 B
Slightly volatile
End Period Cash Flow579.6 M675 M637 M
Slightly volatile
Change To Netincome230.8 M162.9 M638.9 M
Slightly volatile
Dividends Paid229.6 M297 M178.2 M
Slightly volatile
Cash And Cash Equivalents Changes561.6 M631.8 M688.8 M
Slightly volatile
Cash Flows Other Operating1.4 B1.6 B1.7 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.010.5990.873
Pretty Stable
Dividend Yield0.04340.07740.0292
Slightly volatile
Days Sales Outstanding60.3577.412266.5132
Slightly volatile
Free Cash Flow Yield0.280.19920.3175
Slightly volatile
Operating Cash Flow Per Share3.473.65310.3439
Slightly volatile
Stock Based Compensation To Revenue0.01720.01640.0081
Slightly volatile
Capex To Depreciation0.911.32580.6447
Slightly volatile
EV To Sales1.341.88041.2394
Slightly volatile
Free Cash Flow Per Share2.822.97229.6855
Slightly volatile
ROIC0.240.15290.2345
Slightly volatile
Inventory Turnover3.042.03483.7599
Slightly volatile
Net Income Per Share3.193.36136.6347
Slightly volatile
Days Of Inventory On Hand116179110
Slightly volatile
Payables Turnover2.212.331311.1307
Slightly volatile
Sales General And Administrative To Revenue0.160.240.1941
Slightly volatile
Research And Ddevelopement To Revenue0.04410.07320.0451
Slightly volatile
Capex To Revenue0.0280.02730.0228
Slightly volatile
Cash Per Share1.742.6261.5421
Slightly volatile
POCF Ratio3.184.08433.2597
Slightly volatile
Interest Coverage2.712.8577432
Slightly volatile
Payout Ratio0.210.34380.1528
Slightly volatile
Capex To Operating Cash Flow0.140.18640.1086
Slightly volatile
PFCF Ratio4.465.01984.176
Slightly volatile
Days Payables Outstanding95.015769.1309
Slightly volatile
Income Quality1.391.08681.5476
Slightly volatile
EV To Operating Cash Flow6.9412.82235.361
Slightly volatile
PE Ratio3.664.43884.5602
Very volatile
Return On Tangible Assets0.120.12330.3512
Slightly volatile
EV To Free Cash Flow10.3815.75937.4865
Slightly volatile
Earnings Yield0.260.22530.2296
Pretty Stable
Intangibles To Total Assets0.530.46520.501
Slightly volatile
Current Ratio2.261.59972.2413
Slightly volatile
Receivables Turnover5.64.7155.644
Slightly volatile
Graham Number12.8713.5549.138
Slightly volatile
Capex Per Share0.750.68080.6647
Slightly volatile
Revenue Per Share33.1924.909935.308
Slightly volatile
Interest Debt Per Share38.436.569311.9384
Slightly volatile
Debt To Assets0.350.67780.2227
Slightly volatile
Enterprise Value Over EBITDA4.597.50633.7466
Slightly volatile
Short Term Coverage Ratios44.646.9575.2496
Slightly volatile
Price Earnings Ratio3.664.43884.5602
Very volatile
Operating Cycle177257176
Slightly volatile
Days Of Payables Outstanding95.015769.1309
Slightly volatile
Dividend Payout Ratio0.210.34380.1528
Slightly volatile
Price To Operating Cash Flows Ratio3.184.08433.2597
Slightly volatile
Price To Free Cash Flows Ratio4.465.01984.176
Slightly volatile
Pretax Profit Margin0.120.1260.264
Slightly volatile
Ebt Per Ebit0.910.54310.8844
Slightly volatile
Operating Profit Margin0.330.23210.3054
Pretty Stable
Return On Capital Employed0.260.14310.2732
Slightly volatile
Ebit Per Revenue0.330.23210.3054
Pretty Stable
Quick Ratio1.651.11371.6383
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.891.989425.1808
Slightly volatile
Net Income Per E B T0.741.07060.7591
Slightly volatile
Cash Ratio0.220.24830.2091
Slightly volatile
Cash Conversion Cycle112100109
Pretty Stable
Operating Cash Flow Sales Ratio0.140.14670.2844
Slightly volatile
Days Of Inventory Outstanding116179110
Slightly volatile
Days Of Sales Outstanding60.3577.412266.5132
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.90.81360.8939
Slightly volatile
Cash Flow Coverage Ratios0.10.105720.0326
Slightly volatile
Fixed Asset Turnover9.125.48211.7044
Slightly volatile
Capital Expenditure Coverage Ratio5.15.365725.8167
Slightly volatile
Price Cash Flow Ratio3.184.08433.2597
Slightly volatile
Enterprise Value Multiple4.597.50633.7466
Slightly volatile
Debt Ratio0.350.67780.2227
Slightly volatile
Cash Flow To Debt Ratio0.10.105720.0326
Slightly volatile
Price Sales Ratio1.010.5990.873
Pretty Stable
Return On Assets0.06270.06590.1739
Slightly volatile
Asset Turnover0.730.48870.7994
Slightly volatile
Net Profit Margin0.240.13490.1984
Pretty Stable
Gross Profit Margin0.480.58020.5767
Pretty Stable

Organon Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap9.1 B8.9 B8.3 B
Pretty Stable
Enterprise Value8.7 B14.5 B10.7 B
Slightly volatile

Organon Fundamental Market Drivers

Forward Price Earnings5.0302
Cash And Short Term Investments675 M

Organon Upcoming Events

15th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Organon Financial Statements

Organon investors utilize fundamental indicators, such as revenue or net income, to predict how Organon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue236.9 M248.7 M
Total Revenue6.4 B6.1 B
Cost Of Revenue2.7 B2.5 B
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.24  0.16 
Research And Ddevelopement To Revenue 0.07  0.04 
Capex To Revenue 0.03  0.03 
Revenue Per Share 24.91  33.19 
Ebit Per Revenue 0.23  0.33 

Pair Trading with Organon

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will appreciate offsetting losses from the drop in the long position's value.

Moving against Organon Stock

  0.42DRUG Bright Minds BiosciencesPairCorr
  0.4VNDA Vanda PharmaceuticalsPairCorr
  0.34KTTAW Pasithea TherapeuticsPairCorr
  0.31VERA Vera TherapeuticsPairCorr
The ability to find closely correlated positions to Organon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organon Co to buy it.
The correlation of Organon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organon moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Organon offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organon's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organon Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organon Co Stock:
How To Invest In Organon
Details
Is Organon Stock a good investment?
Details
What is Organon's Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Organon Correlation against competitors.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organon. If investors know Organon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organon listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.81)
Dividend Share
1.12
Earnings Share
3.33
Revenue Per Share
24.91
Quarterly Revenue Growth
(0)
The market value of Organon is measured differently than its book value, which is the value of Organon that is recorded on the company's balance sheet. Investors also form their own opinion of Organon's value that differs from its market value or its book value, called intrinsic value, which is Organon's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organon's market value can be influenced by many factors that don't directly affect Organon's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Organon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Organon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY